REAL-LIFE LONG-TERM EFFECTIVENESS AND TREATMENT PERSISTENCE OF VEDOLIZUMAB IN A SINGLE TERTIARY CARE COHORT OF CROHN'S DISEASE PATIENTS

被引：0
|
作者：
Calandrini, L. [1 ]
Salice, M. [1 ]
Hrustemovic, Privitera H. [1 ]
Peruzzi, G. [1 ]
Rizzello, F. [1 ]
Calabrese, C. [1 ]
Scaioli, E. [1 ]
Belluzzi, A. [1 ]
Gionchetti, P. [1 ]
机构：
[1] Policlin St Orsola Malpighi, Bologna, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2020年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T04.01.14
引用
收藏
页码：S123 / S123
页数：1
相关论文
共 50 条
  • [1] Real-life long-term effectiveness and treatment persistence of vedolizumab in a single tertiary care cohort of Crohn's disease patients
    Calandrini, L.
    Salice, M.
    Hrustemovic, H. Privitera
    Peruzzi, G.
    Rizzello, F.
    Calabrese, C.
    Scaioli, E.
    Belluzzi, A.
    Gionchetti, P.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S347 - S348
  • [2] Italian real-life study evaluating the long-term effectiveness of vedolizumab for the treatment of inflammatory bowel disease: the elderly cohort
    Pugliese, D.
    Privitera, G.
    Armuzzi, A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S419 - S420
  • [3] ITALIAN REAL-LIFE STUDY EVALUATING THE LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: THE ELDERLY COHORT
    Pugliese, Daniela
    Privitera, Giuseppe
    Armuzzi, Alessandro
    GASTROENTEROLOGY, 2021, 160 (06) : S43 - S43
  • [4] LONG-TERM EFFECTIVENESS OF USTEKINUMAB IN PATIENTS WITH REFRACTORY CROHN'S DISEASE: A MULTICENTER REAL-LIFE STUDY
    Scribano, M. L.
    Aratari, A.
    Neri, B.
    Bezzio, C.
    Balestrieri, P.
    Falasco, G.
    Camastra, C.
    Pantanella, P.
    Monterubbianesi, R.
    Tullio, A.
    Saibeni, S.
    Papi, C.
    Biancone, L.
    Cosintino, R.
    Faggiani, R.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 : S129 - S129
  • [5] ITALIAN REAL-LIFE STUDY EVALUATING THE LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Pugliese, D.
    Privitera, G.
    Armuzzi, A.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S113 - S114
  • [6] ITALIAN REAL-LIFE STUDY EVALUATING THE LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Pugliese, Daniela
    Privitera, Giuseppe
    Armuzzi, Alessandro
    GASTROENTEROLOGY, 2023, 164 (06) : S1119 - S1120
  • [7] COMPARATIVE OBJECTIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN A REAL-LIFE COHORT OF ACTIVE CROHN'S DISEASE PATIENTS FAILURE TO TNF INHIBITORS
    Onali, S.
    Pugliese, D.
    Caprioli, F. A.
    Orlando, A.
    Biancone, L.
    Nardone, O. M.
    Imperatore, N.
    Fiorino, G.
    Cappello, M.
    Viola, A.
    Principi, M. B.
    Bezzio, C.
    Aratari, A.
    Carparelli, S.
    Mancuso, F.
    Grossi, L.
    Bodini, G.
    Ribaldone, D.
    Mocci, G.
    Favale, A.
    Grova, M.
    Scucchi, L.
    Segato, S.
    Fries, W.
    Castiglione, F.
    Armuzzi, A.
    Fantini, M. C.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S140 - S141
  • [8] Comparative objective effectiveness of vedolizumab and ustekinumab in a real-life cohort of active Crohn's disease patients failure to TNF inhibitors
    Onali, S.
    Pugliese, D.
    Caprioli, F. A.
    Orlando, A.
    Biancone, L.
    Nardone, O. M.
    Imperatore, N.
    Fiorino, G.
    Cappello, M.
    Viola, A.
    Principi, M. B.
    Bezzio, C.
    Aratari, A.
    Carparelli, S.
    Mazzuoli, S.
    Manguso, F.
    Grossi, L.
    Bodini, G.
    Ribaldone, D.
    Mocci, G.
    Minerba, L.
    Favale, A.
    Grova, M.
    Scucchi, L.
    Segato, S.
    Fries, W.
    Castiglione, F.
    Armuzzi, A.
    Fantini, M. C.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I542 - I543
  • [9] Comparative objective effectiveness of vedolizumab and ustekinumab in a real-life cohort of active Crohn's disease patients failure to TNF inhibitors
    Onali, S.
    Pugliese, D.
    Caprioli, F. A.
    Orlando, A.
    Biancone, L.
    Nardone, O. M.
    Imperatore, N.
    Fiorino, G.
    Cappello, M.
    Viola, A.
    Principi, M. B.
    Bezzio, C.
    Aratari, A.
    Carparelli, S.
    Mazzuoli, S.
    Manguso, F.
    Grossi, L.
    Bodini, G.
    Ribaldone, D.
    Mocci, G.
    Minerba, L.
    Favale, A.
    Grova, M.
    Scucchi, L.
    Segato, S.
    Fries, W.
    Castiglione, F.
    Armuzzi, A.
    Fantini, M. C.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I542 - I543
  • [10] Long-term effectiveness of ustekinumab in refractory Crohn's disease: an Italian multicenter real-life study
    Scribano, M. L.
    Aratari, A.
    Neri, B.
    Bezzio, C.
    Balestrieri, P.
    Falasco, G.
    Camastra, C.
    Pantanella, P.
    Monterubbianesi, R.
    Tullio, A.
    Saibeni, S.
    Papi, C.
    Biancone, L.
    Cosintino, R.
    Faggiani, R.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S351 - S351
12345